Featured Press Releases

Aadi Bioscience reports Q3 2024 financial results and updates on corporate progress

Aadi Bioscience reports Q3 2024 financial results and updates on corporate progress

Neurotech Welcomes Industry Veteran Beth Marsh as Chief Commercial Officer

Neurotech Welcomes Industry Veteran Beth Marsh as Chief Commercial Officer

  • 21 Apr 2025

Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative...

At World Sleep 2025, Avadel Pharmaceuticals will present new data on LUMRYZ™ (sodium oxybate) for extended-release oral suspension

At World Sleep 2025, Avadel Pharmaceuticals will present new data on LUMRYZ™ (sodium oxybate) for extended-release oral suspension

Optune Lua® from Novocure has received approval in Japan for treating unresectable advanced/recurrent Non-Small Cell Lung Cancer (NSCLC)

Optune Lua® from Novocure has received approval in Japan for treating unresectable advanced/recurrent Non-Small Cell Lung Cancer (NSCLC)

At the American Thyroid Association meeting, FORE Biotherapeutics presented Phase 1/2a data for Plixorafenib, demonstrating a prolonged duration of effect in BRAF-altered thyroid cancers

At the American Thyroid Association meeting, FORE Biotherapeutics presented Phase 1/2a data for Plixorafenib, demonstrating a prolonged duration of effect in BRAF-altered thyroid cancers

Samsung Biologics Labor Union Warns of

Samsung Biologics Labor Union Warns of "Structural Supply Chain Risk" Amid Labor Dispute, Citing Systemic Governance Failures

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

  • rainStorm Cell Therapeutics Inc.
  • 28 May 2026
Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

  • Nestlé Health Science U.S.
  • 28 May 2026
Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed

Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed

  • Ori Biotech
  • 27 May 2026
SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

  • SK bioscience
  • 27 May 2026
Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

  • LIB Therapeutics Inc.
  • 27 May 2026
Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

  • H. Lundbeck A/S
  • 26 May 2026
The Digital Pharma Advances Conference 2026

Most Popular
May   2026
M T W T F S S
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.